WallStreetZenWallStreetZen

NASDAQ: PRAX
Praxis Precision Medicines Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

PRAX earnings and revenue history

Current Revenue
$2.4M
Current Earnings
-$123.3M
Current Profit Margin
-5,037.9%

PRAX Return on Equity

Current Company
-151%
Current Industry
-63.5%
Current Market
188%
PRAX's Return on Equity (-151%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when PRAX announces earnings.

PRAX Return on Assets

Current Company
-115.6%
Current Industry
2.9%
PRAX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

PRAX Return on Capital Employed

Current Company
-170.75%
Current Industry
19.5%
PRAX's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

PRAX vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
PRAX$2.45M-$122.01M-$123.28MN/AN/A
PROK$0.00-$25.61M-$35.47MN/AN/A
CABA$0.00-$64.18M-$67.68MN/AN/A
ENGNN/AN/AN/AN/AN/A
HLVX$0.00-$119.02M-$123.57MN/AN/A
View Top Biotech Stocks

PRAX earnings dates

Next earnings date
May 9, 2024

Praxis Precision Medicines Earnings & Revenue FAQ

What were PRAX's earnings last quarter?

On Invalid Date, Praxis Precision Medicines (NASDAQ: PRAX) reported Q4 2023 earnings per share (EPS) of -$1.89, up 85.23% year over year. Total Praxis Precision Medicines earnings for the quarter were -$26.88 million. In the same quarter last year, Praxis Precision Medicines's earnings per share (EPS) was -$12.80.

If you're new to stock investing, here's how to buy Praxis Precision Medicines stock.

What was PRAX's earnings growth in the past year?

As of Q2 2024, Praxis Precision Medicines's earnings has grown year over year. Praxis Precision Medicines's earnings in the past year totalled -$123.28 million.

What is PRAX's earnings date?

Praxis Precision Medicines's earnings date is Invalid Date. Add PRAX to your watchlist to be reminded of PRAX's next earnings announcement.

What was PRAX's revenue last quarter?

On Invalid Date, Praxis Precision Medicines (NASDAQ: PRAX) reported Q4 2023 revenue of $515.00 thousand up Infinity% year over year. In the same quarter last year, Praxis Precision Medicines's revenue was $0.00.

What was PRAX's revenue growth in the past year?

As of Q2 2024, Praxis Precision Medicines's revenue has grown null year over year. Praxis Precision Medicines's revenue in the past year totalled $2.45 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.